State of Alaska Department of Revenue Buys 985 Shares of Aflac Incorporated (NYSE:AFL)

State of Alaska Department of Revenue increased its position in Aflac Incorporated (NYSE:AFL) by 1.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 83,922 shares of the financial services provider’s stock after purchasing an additional 985 shares during the period. State of Alaska Department of Revenue’s holdings in Aflac were worth $9,330,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of AFL. Whipplewood Advisors LLC bought a new position in shares of Aflac in the fourth quarter worth approximately $26,000. BankPlus Trust Department purchased a new position in Aflac in the 4th quarter worth approximately $34,000. Curio Wealth LLC bought a new position in Aflac in the 4th quarter valued at approximately $36,000. OFI Invest Asset Management purchased a new stake in Aflac during the 4th quarter valued at $38,000. Finally, Capital A Wealth Management LLC bought a new stake in shares of Aflac in the 4th quarter worth $38,000. Institutional investors own 67.44% of the company’s stock.

Aflac Stock Performance

Shares of AFL opened at $102.56 on Thursday. The business has a 50-day simple moving average of $105.02 and a two-hundred day simple moving average of $105.35. The company has a quick ratio of 0.09, a current ratio of 0.09 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 52 week low of $88.00 and a 52 week high of $115.50. The stock has a market cap of $55.45 billion, a price-to-earnings ratio of 16.02, a PEG ratio of 3.16 and a beta of 0.82.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.67 by ($0.01). Aflac had a net margin of 21.27% and a return on equity of 15.55%. The company had revenue of $3.40 billion for the quarter, compared to the consensus estimate of $4.53 billion. During the same quarter last year, the firm posted $1.66 earnings per share. The company’s revenue was down 37.5% compared to the same quarter last year. On average, analysts expect that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st were paid a $0.58 dividend. The ex-dividend date of this dividend was Wednesday, May 21st. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.26%. Aflac’s dividend payout ratio (DPR) is presently 36.25%.

Insider Activity

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction dated Thursday, May 8th. The stock was sold at an average price of $106.79, for a total transaction of $106,790.00. Following the completion of the sale, the director now owns 26,096 shares in the company, valued at approximately $2,786,791.84. This trade represents a 3.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Arthur Reginald Collins sold 2,750 shares of the business’s stock in a transaction that occurred on Thursday, May 15th. The stock was sold at an average price of $105.70, for a total value of $290,675.00. Following the completion of the transaction, the director now directly owns 6,728 shares in the company, valued at approximately $711,149.60. This represents a 29.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 40,750 shares of company stock worth $4,304,295 in the last three months. Company insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on AFL shares. Wells Fargo & Company upped their price target on Aflac from $102.00 to $103.00 and gave the company an “equal weight” rating in a report on Tuesday, May 6th. Keefe, Bruyette & Woods upped their target price on shares of Aflac from $104.00 to $106.00 and gave the company a “market perform” rating in a research note on Wednesday, May 7th. Piper Sandler lifted their price target on shares of Aflac from $118.00 to $124.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 2nd. UBS Group increased their price objective on shares of Aflac from $109.00 to $114.00 and gave the company a “neutral” rating in a research report on Wednesday, April 2nd. Finally, Wall Street Zen cut shares of Aflac from a “hold” rating to a “sell” rating in a report on Monday, May 5th. Three analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Aflac has an average rating of “Hold” and a consensus price target of $104.93.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.